Literature DB >> 26981642

Ritual Slaughter as Overlooked Risk Factor for Brucellosis.

Inbal Fuchs, Lidia Osyntsov, Yael Refaely, Pnina Ciobotaro, Oren Zimhony.   

Abstract

Entities:  

Keywords:  bacteria; brucellosis; respiratory infections; slaughter

Mesh:

Year:  2016        PMID: 26981642      PMCID: PMC4806964          DOI: 10.3201/eid2204.151192

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: The current rates of animal and human brucellosis in southern Israel are unacceptably high (). Unsupervised livestock rearing, smuggling of herds, and the dissolution of Israel’s “test, slaughter, and compensate” program for small ruminants in 1997 have generated a large, uncontrolled animal reservoir in the region. The Bedouin Arab inhabitants who live in close proximity to herds and consume unpasteurized dairy products are disproportionately affected. Outbreaks from parts of Israel that were previously free of brucellosis are reported with increasing frequency. Moreover, 2 decades after supposed elimination of bovine brucellosis, a cattle herd adjacent to Bedouin grazing areas was found to be highly infected with Brucella melitensis (). We report 5 cases of severe brucellosis in patients from a community whose members typically do not raise herds and do not consume unpasteurized dairy products. The patients were Ethiopian-born Jews who exhibited fever and either respiratory signs or radiologic evidence of new pulmonary findings (Table). The true nature of the infection only became evident when B. melitensis was identified from blood cultures. Directed questioning revealed that all patients participated in ceremonial slaughter of sheep that were purchased from Bedouin owners in southern Israel.
Table

Characteristics, treatment, and outcomes of patients with brucellosis who engaged in ritual slaughter, Israel*Pt no.

Age, y/sexClinical featuresLaboratory findings at admissionChest imagingAlternative diagnosesFever-to- diagnosis interval, dComplicationTreatment and outcome
168/MCervical neck pain; cough; night sweats; 38°CHb, 11.9 mg/dL; leukocytes, 16.3 × 103 /μL; AST, 63 U/L; ALT, 118 U/LCT: apical lung finding, new onsetAsthma exacerbation; lung malignancy21Focal lung lesion; relapse: epididymo-orchitis; suspected osteomyelitis C6: increased uptake bone scanSTR/2 wk, dox + cipro/6 wk; relapse: rising Brucella titers + epididymitis; same 3 drugs/12 wk; recovery
270/M1st admission: fever; productive coughHb,14.9 mg/dL; leukocytes, 12 x 103 cells/μL; platelets, 136 x 103/μL; AST, 61 U/L; ALT, 47 U/LChest radiograph: retrocardial infiltrateAsthma exacerbation; bronchitisNAInhalatants: IV solumedrol, then oral prednisone
2nd admission: hypothermia: 35.7°C; pulse oximetry, 94% on room airHb: 12 mg/dL; leukocytes, 2.8 x 103 cells/ μL, 3.7 x 103 cells/μL; platelets, 38 x 103/μL; Na, 129 meq/L; AST, 134 U/L; ALT, 100 U/LCT: multiple RUL pulmonary nodules; mediastinal lymphadenopathyTB92SepsisSTR/2 wk, dox/6 wk: recovery
345/MFever; prolonged headache Hb, 11.7 mg/dL; AST, 58 U/L; ALT, 102 U/L; Na, 133 meq/L; ESR, 70 mm Hg/hChest radiograph: diffuse bilateral pulmonary nodules rule out miliary TBTB; cryptococcal meningitis21Suspected discitis C5–6 per MRIGenta/wk, dox + cotrim/12 wk; recovery
455/MCough; fever; low back painHb, 11.8 mg/dL; AST, 86 U/L; ALT, 120 U/L; ESR, 90 mm Hg/h; CRP, 92.6 mg/LChest radiograph: peribronchial thickeningPneumonia (rx cefuroxime); temporal arteritis28Genta/2 wk, dox/6 wk; persistent low back pain
549/FCough; feverHb, 9.5 mg/dL; leukocytes, 3.7 x 103 cells/μL; platelets, 116 x 103/μLChest radiograph: no pathologic changes; CT: no pathologic changesTB; infective endocarditis caused by Actinobacillus ureae90Genta/2 wk; dox + rif/7 wk; recovery

*Pt, patient; lab, laboratory; Hb, hemoglobin; leukocyte: leukocytes; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CT, computed tomographic scan; C6, cervical vertebra 6; STR, streptomycin; dox, doxycycline; cipro, ciprofloxacin; NA, not available; IV, intravenous; Na, sodium; RUL, right upper lobe; TB, tuberculosis; ESR, erythrocyte sedimentation rate; MRI, magnetic resonance imaging; genta, gentamicin; cotrim, cotrimoxazole; CRP, C-reactive protein; rx, prescription; rif, rifampin.

*Pt, patient; lab, laboratory; Hb, hemoglobin; leukocyte: leukocytes; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CT, computed tomographic scan; C6, cervical vertebra 6; STR, streptomycin; dox, doxycycline; cipro, ciprofloxacin; NA, not available; IV, intravenous; Na, sodium; RUL, right upper lobe; TB, tuberculosis; ESR, erythrocyte sedimentation rate; MRI, magnetic resonance imaging; genta, gentamicin; cotrim, cotrimoxazole; CRP, C-reactive protein; rx, prescription; rif, rifampin. The diagnostic pitfalls encountered by the medical staff are exemplified in the case of patient 1 (Table). In May 2014, this 68-year-old man was admitted to a hospital in southern Israel, with a 14-day history of fever, cough, and night sweats. His medical history was notable for asthma and previously treated pulmonary tuberculosis (TB). Computed tomography scan of his chest showed a new 1.5-cm2 apical lung lesion with irregular borders. Laboratory evaluations were negative for rickettsiae, Coxiella burnetii, HIV, Plasmodium spp., and Mycobacterium tuberculosis. Four days after admission, gram-negative coccobacilli grew from his blood culture. Brucella IgM titer was 1:1,920. The patient received appropriate treatment for 6 weeks (Table) and recovered. Brucella IgM titers dropped to 1:40. Four months later, he returned to the infectious diseases clinic exhibiting fever, chills, and clinical and sonographic evidence of epididymo-orchitis. Brucella IgM titers rose to 1:1,240. Treatment was resumed for 3 months. In addition, a thoracoscopic biopsy of the lung lesion was performed to rule out malignancy. Pathologic examination of the biopsy specimen revealed a focus of fibrosis, with giant cells surrounded by lymphocytes (Technical Appendix Figure). After treatment, the patient’s symptoms resolved and titers returned to low levels. The long symptom-to-diagnosis interval (range 21–97 days) for patients in this report is alarming (Table). Treatment delays are associated with increased focal complications and relapse rates (). Further, high case-fatality rates, allegedly due to low physician awareness, were reported in a largely immigrant cohort of brucellosis patients in Germany (). Several circumstances might have led to the failure to include brucellosis in the initial differential diagnosis for these patients, even in a disease-endemic region. First, we can assume that physicians are unfamiliar with the ceremonial slaughter central to the celebrations of Ethiopian Jews. The tradition includes slaughtering, skinning, and eviscerating a sheep, followed by mincing of the sheep meat. This venerated ritual is performed by trained members of the Ethiopian community and supervised by the spiritual leader, the Kes (). Second, patients were consistently reluctant to disclose their participation in ceremonial slaughter to medical staff. Third, the managing physicians considered differential diagnoses for febrile respiratory illness in line with the patients’ Ethiopian origins: reactivation of TB or chronic pulmonary disease exacerbation (). Patients 3 and 5 had a history of prolonged cough at admission; patient 3 had chest radiograph results suggestive of miliary TB. Finally, for patient 5, Actinobacillus ureae was initially but erroneously identified as the cause of bacteremia. All patients in our study had clinical or radiologic evidence of lung involvement. Causality between exposure to Brucella-infected aerosols and pulmonary manifestations of brucellosis has been demonstrated in animal models. After an aerosol challenge with B. melitensis, animal lungs have shown perivascular inflammation as well as microgranulomas (). In a study of hunters infected with B. suis, in which 38% had respiratory symptoms, aerosol spread or conjuctival innoculation was considered the most likely route of infection (). Aerosol exposure during slaughter could be linked to the pulmonary manifestations of brucellosis observed in these patients. The granulomatous changes in the lung biopsy specimens of patient 1 are typical of lung involvement in brucellosis (). The patients in this report did not use protective gear during contact with animal parts, which inevitably increased their risk for infection through direct or aerosol contact (). This reports illustrates an unsuspected mode of brucellosis transmission in an area with soaring brucellosis rates: transmission from infected animals to persons clandestinely engaging in ritual slaughter; specifically, an Ethiopian Jewish community. Physicians in countries receiving immigrants should be aware of ceremonial practices that place patients at risk for zoonoses. The severe respiratory manifestations that ensued following aerosol exposure to animal blood or secretions suggest that brucellosis with pulmonary involvement after inhalation of Brucella-infected aerosols might be more common than previously documented.

Technical Appendix

Pathologic examination results for a patient with brucellosis, Israel, 2014.
  6 in total

1.  Pathophysiology of the rhesus macaque model for inhalational brucellosis.

Authors:  Lisa N Henning; Stephen M Miller; Dennis H Pak; Amber Lindsay; David A Fisher; Roy E Barnewall; Crystal M Briscoe; Michael S Anderson; Richard L Warren
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

2.  An unusually high prevalence of asthma in Ethiopian immigrants to Israel.

Authors:  R Rosenberg; S Vinker; H Zakut; F Kizner; S Nakar; E Kitai
Journal:  Fam Med       Date:  1999-04       Impact factor: 1.756

3.  Brucellosis in northern Australia.

Authors:  Katie M Eales; Robert E Norton; Natkunam Ketheesan
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

4.  Brucellosis of the lung: case report and review of the literature.

Authors:  Dirk Theegarten; Sven Albrecht; Martin Tötsch; Helmut Teschler; Heinrich Neubauer; Sascha Al Dahouk
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

5.  Survey of Brucella infection and malaria among Abattoir workers in Kampala and Mbarara Districts, Uganda.

Authors:  Immaculate Nabukenya; Deogratius Kaddu-Mulindwa; George William Nasinyama
Journal:  BMC Public Health       Date:  2013-09-30       Impact factor: 3.295

6.  Changing epidemiology of human brucellosis, Germany, 1962-2005.

Authors:  Sascha Al Dahouk; Heinrich Neubauer; Andreas Hensel; Irene Schöneberg; Karsten Nöckler; Katharina Alpers; Hiltrud Merzenich; Klaus Stark; Andreas Jansen
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

  6 in total
  2 in total

1.  Rethinking "One Health" through Brucellosis: ethics, boundaries and politics.

Authors:  Barak Hermesh; Anat Rosenthal; Nadav Davidovitch
Journal:  Monash Bioeth Rev       Date:  2019-10

Review 2.  A Review of Infectious Diseases Associated with Religious and Nonreligious Rituals.

Authors:  Kiran Gajurel; Stan Deresinski
Journal:  Interdiscip Perspect Infect Dis       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.